Your browser doesn't support javascript.
loading
Simplifying the Execution of HepatoPac MetID Experiments: Metabolite Profile and Intrinsic Clearance Comparisons.
Ballard, T Eric; Kratochwil, N; Cox, Loretta M; Moen, Mark A; Klammers, F; Ekiciler, A; Goetschi, A; Walter, I.
Affiliation
  • Ballard TE; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, Connecticut (T.E.B., L.M.C., M.A.M.) and Drug Disposition and Safety, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland (N.K., F.K., A.E., A.G., I.W.) eric.ballard@takeda.com.
  • Kratochwil N; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, Connecticut (T.E.B., L.M.C., M.A.M.) and Drug Disposition and Safety, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland (N.K., F.K., A.E., A.G., I.W.).
  • Cox LM; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, Connecticut (T.E.B., L.M.C., M.A.M.) and Drug Disposition and Safety, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland (N.K., F.K., A.E., A.G., I.W.).
  • Moen MA; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, Connecticut (T.E.B., L.M.C., M.A.M.) and Drug Disposition and Safety, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland (N.K., F.K., A.E., A.G., I.W.).
  • Klammers F; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, Connecticut (T.E.B., L.M.C., M.A.M.) and Drug Disposition and Safety, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland (N.K., F.K., A.E., A.G., I.W.).
  • Ekiciler A; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, Connecticut (T.E.B., L.M.C., M.A.M.) and Drug Disposition and Safety, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland (N.K., F.K., A.E., A.G., I.W.).
  • Goetschi A; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, Connecticut (T.E.B., L.M.C., M.A.M.) and Drug Disposition and Safety, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland (N.K., F.K., A.E., A.G., I.W.).
  • Walter I; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, Connecticut (T.E.B., L.M.C., M.A.M.) and Drug Disposition and Safety, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland (N.K., F.K., A.E., A.G., I.W.).
Drug Metab Dispos ; 48(9): 804-810, 2020 09.
Article in En | MEDLINE | ID: mdl-32623369
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Metabolomics / Primary Cell Culture / Hepatobiliary Elimination Type of study: Qualitative_research Language: En Journal: Drug Metab Dispos Year: 2020 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Metabolomics / Primary Cell Culture / Hepatobiliary Elimination Type of study: Qualitative_research Language: En Journal: Drug Metab Dispos Year: 2020 Type: Article